|
Form Serial Number: |
DA20191108E00415
|
1.
Date of relevant event: |
28/10/2019 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
06855 |
4.
Name of listed corporation: |
Ascentage Pharma Group International |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
207,074,627 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Zhao |
(Other names) |
Qun |
|
|
|
10.
Name of director (Chinese): |
趙群 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1701 | Miscellaneous On listing of the corporation or a class of shares of the listed corporation | |
|
|
|
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
| | |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 4,712,135 | 2.27 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
| |
2201 | Interest of corporation controlled by you |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 28/10/2020 | 15/08/2028 | | | HKD | 0.010 | | | 73,178 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 28/10/2021 | 15/08/2028 | | | HKD | 0.010 | | | 73,178 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 28/10/2022 | 15/08/2028 | | | HKD | 0.010 | | | 73,179 |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 28/10/2023 | 15/08/2028 | | | HKD | 0.010 | | | 73,179 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Oriza Seed Limited | Floor 2, Block 16, Sandlake VC/PE Community, 183 Suhong Dong Rd., Suzhou Industrial Park, Jiangsu, China. Place of incorporation: Cayman Islands | Zhao Qun | 40.00 | N | |
Oriza Seed L.P. | Harneys Fiduciary (Cayman) Limited, 4th Floor, Harbour Place, 103 South Church Street, PO Box 10240, Grand Cayman KY1-1002, Cayman Islands - Cayman Islands | Oriza Seed Limited | 100.00 | N | |
Oriza Seed Fund I L.P. | Harneys Fiduciary (Cayman) Limited, 4th Floor, Harbour Place, 103 South Church Street, PO Box 10240, Grand Cayman KY1-1002, Cayman Islands - Cayman Islands | Oriza Seed L.P. | 100.00 | Y | |
Oriza Seed Venture Capital II Limited | Floor 2, Block 16, Sandlake VC/PE Community, 183 Suhong Dong Rd., Suzhou Industrial Park, Jiangsu, China. Place of incorporation: British Virgin Islands | Zhao Qun | 100.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
(1) Mr. Zhao Qun held share options to subscribe for 292,714 shares. (2) Mr. Zhao Qun owned 40% interest in Oriza Seed Limited, which is the general partner of and also held 50% interest in Oriza Seed L.P., which is in turn the general partner of and also held 1% interest in Oriza Seed I L.P. which directly held 2,511,741 shares. (3) Mr. Zhao is the sole director of Oriza Seed Venture Capital II Limited which directly held 1,907,680 shares.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
08/11/2019 (dd/mm/yyyy)
|
|